First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy.
Djaldetti
R
R
Achiron
A
A
Ziv
I
I
Melamed
E
E
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000601:surgery*; D005260:Female; D005746:Gastric Emptying / Q000502:physiology; D005772:Gastrointestinal Transit / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011183:Postoperative Complications / Q000188:drug therapy* / Q000503:physiopathology; D014628:Vagotomy; D014630:Vagus Nerve / Q000503:physiopathology
D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa